InsidersTradesSigma
Terns Pharmaceuticals, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Terns Pharmaceuticals, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Terns Pharmaceuticals, Inc. has logged 57 insider filings. Market capitalisation: €1,106bn. The latest transaction was filed on 2 April 2026 (Cession). Among the most active insiders: Vignola Mark J.. The full history is openly available.
57
Insider Decl.
0
Thresholds
€37m
30 ops.
Buy Volume
€7m
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Terns Pharmaceuticals, Inc. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,486.00.
59Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,535 of 26,179 companies
58.5
score / 100
Value38
Quality79
FCF yld0.2%
Earn yld0.8%
EV/EBITDA·
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 April 2026
Declarations57 total
942 shares@ US$52.752661.4% of flowCommon StockSEC:0001892413-26-000006:0
14,583 shares@ US$4.6424.3% of flowCommon StockSEC:0001872564-26-000008:0
56,250 shares0Common StockSEC:0001892413-26-000004:0
150,000 shares0Common StockSEC:0001872564-26-000004:0
68,750 shares0Common StockSEC:0001563623-26-000002:0
200 shares@ US$39.60Common StockSEC:0001892413-26-000002:0
21,551 shares@ US$4.64Common StockSEC:0001872564-26-000002:0
24,520 shares@ US$9.2460.1% of flowCommon StockSEC:0001799780-25-000004:0
944 shares@ US$7.84648.0% of flowCommon StockSEC:0001892413-25-000004:0
853 shares@ US$4.26714.2% of flowCommon StockSEC:0001562180-25-005308:0
5,000 shares@ US$3.926751.0% of flowCommon StockSEC:0001562180-25-005120:0
Ideal exit: 24 Mar 2026 (T+270)
23,314 shares@ US$3.870241.8% of flowCommon StockSEC:0001562180-25-005077:0
Ideal exit: 22 Mar 2026 (T+270)
5,000 shares@ US$3.75100.0% of flowCommon StockSEC:0001562180-25-004866:0
Ideal exit: 10 Mar 2026 (T+270)
952 shares@ US$2.48518.1% of flowCommon StockSEC:0001562180-25-002920:0
2,250 shares@ US$5.11100.0% of flowCommon StockSEC:0001562180-25-000853:0
Ideal exit: 27 Aug 2025 (T+270)
510 shares@ US$5.112.3% of flowCommon StockSEC:0001562180-25-000851:0
Ideal exit: 27 Aug 2025 (T+270)
8,129 shares@ US$5.723232.2% of flowCommon StockSEC:0001562180-25-000220:0
6,240 shares@ US$5.721526.4% of flowCommon StockSEC:0001562180-25-000219:0
4,481 shares@ US$5.714691.9% of flowCommon StockSEC:0001562180-25-000221:0
15,450 shares@ US$7.1597.7% of flowCommon StockSEC:0001562180-24-008254:0
Ideal exit: 1 Sept 2025 (T+270)
10,000 shares@ US$5.3634.9% of flowCommon StockSEC:0001562180-24-006794:0
17,235 shares@ US$1.8221.8% of flowCommon StockSEC:0001562180-24-006776:0
6,143 shares@ US$7.675133.5% of flowCommon StockSEC:0001562180-24-006019:0
39,433 shares@ US$10.005.0% of flowCommon StockSEC:0000947871-24-000627:0
25 of 57 declarations
About Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for metabolic and liver diseases. It is listed on NASDAQ under the ticker TERN.